POST LEONARD E

SEC Form 4 insider trading activity

POST LEONARD E has filed 11 SEC Form 4 filings (22 transaction rows) across 2 companies, including CGON, QURE, with disclosures dating back to 2025. 11 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.

On the most recent filing, POST LEONARD E is listed as Director at CG Oncology, Inc. Inside the rolling window, POST LEONARD E reported no open-market purchases and 11 open-market sales totaling $1.3M in CGON and QURE. The largest disclosed transaction in the window is a sale of 5,000 CGON shares on Jun 24, 2026, worth $350K.

Companies traded

Other insiders at CGON

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.3M

reported sales (SEC code S)

Companies

2

in the rolling window

Source
CGONSale$75KAug 18SEC ↗
CGONSale$71KJul 17SEC ↗
CGONSale$350KJun 25SEC ↗
CGONSale$325KJun 23SEC ↗
QURESale$54KJun 12SEC ↗
CGONSale$55KJun 5SEC ↗
CGONSale$41KNov 18SEC ↗
CGONSale$43KOct 15SEC ↗
CGONSale$200KOct 1SEC ↗
CGONSale$35KSep 16SEC ↗
CGONSale$28KSep 4SEC ↗

Frequently asked questions

How many SEC Form 4 filings has POST LEONARD E made?

POST LEONARD E has filed 11 SEC Form 4 filings (22 transaction rows) across 2 companies, including CGON, QURE since 2025.

Which companies does POST LEONARD E trade?

POST LEONARD E has filed SEC Form 4 disclosures for 2 companies, including CGON, QURE.

When was POST LEONARD E's most recent SEC Form 4 filing?

POST LEONARD E's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.

What is POST LEONARD E's total buy and sell value in the current window?

Inside the rolling retention window, POST LEONARD E bought $0 and sold $1.3M based on SEC Form 4 filings.

What was POST LEONARD E's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 5,000 CGON shares on 2026-06-24, worth $350K, per SEC Form 4 filings.